Latest in Medicare announces weight loss drugs, including Ozempic, will be up for price negotiations
Sort by
896 items
-
Obesity drugs Ozempic and Wegovy included in US price-cut talks
Novo Nordisk shares hit as government adds blockbuster weight-loss treatments to new round of negotiationsFinancial Times - 1h -
Biden to Commute Drug Offender Sentences
The action, aimed at inmates who received harsher sentences based on old disparities in drug laws, is the broadest commutation of individual sentences ever issued by a U.S. president.The New York Times - 1h -
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.CNBC - 6h -
Ozempic Among the Next Drugs Up for Medicare Price Negotiations
The list of drugs account for $41 billion in annual Medicare spending, the Biden administration said.The Wall Street Journal - 6h -
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.The New York Times - 9h -
The next 15 drugs chosen for Medicare negotiation
The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts before the inauguration of President-elect Trump. The Centers for Medicare ...The Hill - 7h -
White House says popular weight-loss drug Ozempic subject to Medicare talks
Analysts at Argus Research say the stock is now trading at 22 times its estimated 2025 earnings.MarketWatch - 7h -
Medicare announces weight-loss drugs, including Ozempic, will be up for price negotiations
The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.NBC News - 7h -
Ozempic, Wegovy on list for Medicare drug price negotiations
The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.CBS News - 8h -
CMS to seek Medicare negotiations on Ozempic price
The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation. CMS listed Ozempic, Rybelsus and Wegovy — all forms of semaglutide ...The Hill - 9h -
Biden administration picks 15 more drugs for Medicare negotiation
The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing the selection two weeks ahead of schedule. Administration officials did ...The Hill - 9h -
UPS could help end the ‘freight recession’ this year. It may have to raise prices first.
Analysts say deregulation, lower taxes under Trump could spur small-business investments and more shipments — but tariffs could weigh down volumes.MarketWatch - 1d -
How Roki Sasaki finalists can get a leg up in contract negotiations for Japanese ace
Sasaki has reportedly narrowed his suitors down to three teamsCBS Sports - 1d -
Medicare's new $2,000 cap on out-of-pocket drug costs could save patients thousands, AARP says
The AARP report suggests the spending cap could be huge for Medicare enrollees who take costly drugs for cancer, rheumatoid arthritis, and other conditions.CNBC - 1d -
-
Top 3 drug insurers reaped billions as their drug middlemen inflated prices, FTC alleges
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from ‘excess’ prescription price hikes of 1,000% or more.NBC News - 3d -
Los Angeles Is Being Crushed Under the Weight of Inaction
At this point, we’d take concepts of a plan.The New York Times - 3d -
Eli Lilly CEO expects new weight loss pill to be approved next year
Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which dominate the weight loss drug market.CNBC - 4d -
Eli Lilly strikes deal for cancer treatment, gives timeline for weight loss pill
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.CNBC - 4d -
GSK to buy US cancer drug firm IDRx for up to $1.15bn
Massachusetts-based company is working on new treatments for gastrointestinal cancers. Business live – latest updates GSK has struck a deal worth up to $1.15bn (£950m) to acquire a ...The Guardian - 4d -
The King of Ozempic Is Scared as Hell
Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?Wired - 4d -
'I feel blessed to get weight-loss jab' - but can the NHS afford it for all?
We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.BBC News - 4d -
New York City's congestion pricing picks up speed
The first congestion pricing plan in the U.S. has begun, charging most drivers $9 a day to enter the lower half of Manhattan. The long-debated plan is projected to raise up to $800 million a year ...CBS News - 5d -
Baby boomers and ‘Ozempic face’ drive injectables craze
People ‘want to look what they feel like, not what they may look like’ says dermatology giant GaldermaFinancial Times - 5d -
High cost of weight loss drugs drives employers to require nutrition counseling, in boost for startups
Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss management program.CNBC - Jan. 10 -
'Three-weight champion & retire by 30' - Dubois dreams big
World champion Caroline Dubois plots her journey to superstardom within six years and addresses the publicised family feud with her father and brother.BBC News - Jan. 10 -
Prices of top 25 Medicare Part D drugs have nearly doubled, AARP study finds
AARP's new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing Medicare to negotiate prices.CNBC - Jan. 9 -
Loss estimates, including health effects and rebuilding costs, surge.
As fires raged, the economic toll of the disaster climbed into the tens of billions of dollars, according to analyst estimates.The New York Times - Jan. 9 -
How Trump’s Greenland Plan Could Hit Ozempic, Legos and Hearing Aids
Putting tariffs on Denmark unless it cedes the island of Greenland could hurt access to a few key products, including popular medicines.The New York Times - Jan. 9 -
Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.NBC News - Jan. 9 -
Insurers brace for losses of up to $20bn from California wildfires
JPMorgan analysts double estimates as blazes continue to rageFinancial Times - Jan. 9 -
Xbox Developer Direct Announced For This Month, Includes "Brand-New Game"
The next Xbox Developer Direct event is coming up soon. Microsoft has announced a new Xbox Developer Direct broadcast for January 23, and it will feature a number of games like South of Midnight ...GameSpot - Jan. 9 -
Smith dumps Diageo stake over impact of weight-loss drugs on alcohol demand
Veteran stockpicker sells shares in spirits brand because drinks sector is being ‘impacted negatively’Financial Times - Jan. 9 -
Ketamine could be reclassified as Class A drug
Illegal use of the drug reached record levels last year, the Home Office said.BBC News - Jan. 7 -
Davis and Zalatoris pay price of wrong ball mix-up
Cameron Davis and Will Zalatoris miss out on thousands of pounds in prize money after a mix-up at The Sentry tournament in Hawaii.Yahoo Sports - Jan. 6 -
UK businesses plan price increases as Budget drives up costs
Tax and wage rises have caused confidence to ‘slump’, warns British Chambers of CommerceFinancial Times - Jan. 5 -
What’s going to happen with Social Security and Medicare in 2025?
What retirees should know about these important benefits heading into the new year.MarketWatch - Jan. 4 -
Pharma giant seeks to join lawsuit against FDA over weight loss drugs
Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the "entitlement" some ...The Hill - Jan. 2
